137 related articles for article (PubMed ID: 24712694)
1. Valentine's Day PSA.
Dasgupta P
BJU Int; 2014 Feb; 113(2):177. PubMed ID: 24712694
[No Abstract] [Full Text] [Related]
2. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
3. Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations.
Loeb S
BJU Int; 2015 Apr; 115(4):500. PubMed ID: 25808708
[No Abstract] [Full Text] [Related]
4. PSA and prostate cancer diagnosis.
Savage P; Waxman J
Eur J Cancer; 1996 Jun; 32A(7):1097-9. PubMed ID: 8758236
[No Abstract] [Full Text] [Related]
5. Prostate cancer: estimating the benefits of PSA screening.
Vickers AJ; Lilja H
Nat Rev Urol; 2009 Jun; 6(6):301-3. PubMed ID: 19498406
[TBL] [Abstract][Full Text] [Related]
6. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
Siegel C
J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
[No Abstract] [Full Text] [Related]
7. Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
Ulmert D; O'Brien MF; Bjartell AS; Lilja H
Nat Rev Urol; 2009 Jul; 6(7):384-91. PubMed ID: 19578355
[TBL] [Abstract][Full Text] [Related]
8. [PSA-screening: sensible or meaningless?].
Dubben HH
Urologe A; 2009 Sep; 48(9):1103; author reply 1103-4. PubMed ID: 19727645
[No Abstract] [Full Text] [Related]
9. Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed.
Carter HB
Oncology (Williston Park); 2014 Feb; 28(2):155-6. PubMed ID: 24701706
[No Abstract] [Full Text] [Related]
10. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.
McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA
Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589
[No Abstract] [Full Text] [Related]
11. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
Boyle P
Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
[No Abstract] [Full Text] [Related]
12. [Do current studies really prove the uselessness of PSA screening? : Attempt at a critical interpretation of the publicized data and the resulting echoes in the media].
Stöckle M
Urologe A; 2009 Aug; 48(8):912-6. PubMed ID: 19618157
[No Abstract] [Full Text] [Related]
13. [PSA and blood test diagnostics of prostate cancer].
Seikkula H; Pettersson K; Boström PJ
Duodecim; 2015; 131(17):1547-52. PubMed ID: 26548101
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers?
Egidi MG; Cochetti G; Serva MR; Guelfi G; Zampini D; Mechelli L; Mearini E
Biomed Res Int; 2013; 2013():241780. PubMed ID: 24288670
[TBL] [Abstract][Full Text] [Related]
15. Prostate Health Index (PHI): golden bullet or just another prostate cancer marker?
Loeb S
Eur Urol; 2013 Jun; 63(6):995-6; discussion 996-7. PubMed ID: 23453055
[No Abstract] [Full Text] [Related]
16. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
[TBL] [Abstract][Full Text] [Related]
17. [Biological markers of prostate cancer].
Seitz C; Djavan B
Ann Urol (Paris); 2006 Dec; 40(6):329-35. PubMed ID: 17214230
[TBL] [Abstract][Full Text] [Related]
18. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.
Ström P; Nordström T; Aly M; Egevad L; Grönberg H; Eklund M
Eur Urol; 2018 Aug; 74(2):204-210. PubMed ID: 29331214
[TBL] [Abstract][Full Text] [Related]
19. [Prostate Specific Antigen (PSA), yet how much damage?].
Braillon A; Hill C; Dubois G
Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
[TBL] [Abstract][Full Text] [Related]
20. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
Borkowetz A
Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
[No Abstract] [Full Text] [Related]
[Next] [New Search]